Mitsubishi UFJ Asset Management
RPTX

Mitsubishi UFJ Asset Management’s Repare Therapeutics RPTX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,580
Closed -$165K – 1193
2022
Q1 		$165K Buy
11,580
+1,002
+9% +$14.9K ﹤0.01% 1083
2021
Q4 		$231K Buy
10,578
+1,599
+18% +$37.7K ﹤0.01% 1060
2021
Q3 		$236K Buy
8,979
+243
+3% +$7.85K ﹤0.01% 1037
2021
Q2 		$272K Buy
+8,736
New +$286K ﹤0.01% 1054

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management's RPTX Position: Q2 2022 in Review

Mitsubishi UFJ Asset Management sold out of Repare Therapeutics (RPTX) in Q2 2022, closing a stake of 11,580 shares — an estimated $165K sold.

Mitsubishi UFJ Asset Management first reported a position in RPTX in Q2 2021 and held it in 4 quarters. The position peaked at $272K in Q2 2021. 71 funds tracked by Wall St. Rank hold RPTX as of Q2 2022.

  • Mitsubishi UFJ Asset Management reported no remaining Repare Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 11,580 Repare Therapeutics shares in Q2 2022, an estimated $165K.
  • Mitsubishi UFJ Asset Management first reported a position in Repare Therapeutics in Q2 2021 and held it in 4 quarters.
  • Mitsubishi UFJ Asset Management's Repare Therapeutics position peaked at $272K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.